Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C., and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Listen to Dr. Boudadi’s Cancer Matters podcast episode to learn more about his work. Dr. Boudadi has expertise in treating cancers of the head and neck, including salivary gland cancers, as well as cancers of the esophagus, and bone and soft tissue sarcomas. Having completed dual training in medical oncology and hematology at Johns Hopkins University, Dr. Boudadi also treats patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders, and clotting disorders. Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy. Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine. Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy. Recent News Articles and Media Coverage Cancer Matters Podcast: Dr. Bill Nelson discussing the treatment of HPV related head and neck cancers, Johns Hopkins Kimmel Cancer Center Podcasts (May 23, 2019). Dr. Boudadi is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Glioma, Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Prostatectomy.

Andrew Tiu is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Tiu is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Myeloproliferative Neoplasms (MPN), Plummer-Vinson Syndrome, Cavernous Sinus Thrombosis, Lymphofollicular Hyperplasia, and Salpingo-Oophorectomy.

Craig Kessler is a Hematologist in Washington, Washington, D.c.. Dr. Kessler is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Blood Clots, Hemophilia A, Acquired Hemophilia, Bone Marrow Aspiration, and Splenectomy.

Maneesh Jain is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Jain is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Pancreatic Cancer, Myeloproliferative Neoplasms (MPN), Iron Deficiency Anemia, Hepato-Pancreato-Biliary Surgery, and Bone Marrow Transplant.

Zoe Mckinnell is a primary care provider, practicing in Internal Medicine in Washington, Washington, D.c.. Dr. Mckinnell is rated as an Advanced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Myeloproliferative Neoplasms (MPN), Leukemia, Multicentric Castleman Disease (MCD), and Acute Myeloid Leukemia (AML).

Scott Rowley is an Oncologist and a Hematologist in Washington, Washington, D.c.. Dr. Rowley is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Colonoscopy.

Natasha Mathur is a primary care provider, practicing in Internal Medicine in Washington, Washington, D.c.. Dr. Mathur is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top area of expertise is Myeloproliferative Neoplasms (MPN).

Vera Malkovska is a Hematologist in Washington, Washington, D.c.. Dr. Malkovska is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Sickle Cell Disease, and Bone Marrow Aspiration.

Julia Cunningham is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Cunningham is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Thrombocytopenia, Essential Thrombocythemia, Adult Immune Thrombocytopenia, Pulmonary Embolism, and Bone Marrow Aspiration. Dr. Cunningham is currently accepting new patients.

Aarthi Shenoy is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Shenoy is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration.

Deepak Chander is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Chander is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC).

Kamyar Nader is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Nader is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Sickle Cell Disease, Follicular Lymphoma, and Bone Marrow Aspiration.

Mervat Saleh is an Oncologist and a Hematologist in Washington, Washington, D.c.. Dr. Saleh is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Multiple Myeloma, and Inflammatory Breast Cancer. Dr. Saleh is currently accepting new patients.

Catherine Bishop is a Nurse Practitioner in Washington, Washington, D.c.. Ms. Bishop is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Smoldering Multiple Myeloma, Small Lymphocytic Lymphoma (SLL), ALK-Positive Non-Small Cell Lung Cancer, and T-Cell Lymphoma.

Ravi Sarma is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Sarma is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Anemia, Breast Cancer, Thrombocytopenia, and Paget Disease of the Breast.

Catherine Broome is a Hematologist in Washington, Washington, D.c.. Dr. Broome is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Autoimmune Hemolytic Anemia, Chronic B-Cell Leukemia (CBCL), Thrombocytopenia, Bone Marrow Aspiration, and Splenectomy.

Alain Mina is a Hematologist Oncology specialist and a Hospital Medicine provider in Washington, Washington, D.c.. Dr. Mina is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Myelodysplastic Syndrome (MDS), Lung Adenocarcinoma, Leukemia, and Bone Marrow Transplant.

Bahar Burak is a Transfusion Medicine provider in Washington, Washington, D.c.. Dr. Burak is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Multisystem Inflammatory Syndrome in Children (MIS-C), Smoldering Multiple Myeloma, Myeloproliferative Neoplasms (MPN), and Neonatal Sepsis.